SKIBSTED RUSSELL Insider Trading Activity (PCSA)

Summary

Updated Jul 16, 2026

SKIBSTED RUSSELL has filed 6 SEC Form 4 filings across 1 company in the last 90 days — buying. Lifetime open-market purchases: $42K.

Profile

Russell Skibsted is the Chief Financial Officer of Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing next-generation chemotherapy oncology drugs. He has been involved in the company's financial operations as indicated by his role and SEC filings.

Role	Insider
Notability	20/100

Board memberships

Processa Pharmaceuticals, Inc.

Recent Transactions

Date	Ticker	Company	Code	Shares	Price	Value
2026-07-01	PCSA	Processa Pharmaceuticals, Inc.	P — Open-market purchase	3.3K	$1.93	$6K
2026-06-16	PCSA	Processa Pharmaceuticals, Inc.	P — Open-market purchase	2.7K	$2.22	$6K
2026-06-01	PCSA	Processa Pharmaceuticals, Inc.	P — Open-market purchase	2.3K	$2.57	$6K
2026-05-19	PCSA	Processa Pharmaceuticals, Inc.	P — Open-market purchase	2.0K	$2.97	$6K
2026-05-01	PCSA	Processa Pharmaceuticals, Inc.	P — Open-market purchase	2.2K	$2.69	$6K
2026-04-17	PCSA	Processa Pharmaceuticals, Inc.	P — Open-market purchase	2.0K	$2.97	$6K
2026-04-01	PCSA	Processa Pharmaceuticals, Inc.	P — Open-market purchase	2.3K	$2.54	$6K

Frequently Asked Questions

Who is SKIBSTED RUSSELL?

How many SEC Form 4 filings has SKIBSTED RUSSELL submitted recently?

6 primary Form 4 filings in the last 90 days, covering 1 company.

Has SKIBSTED RUSSELL been buying or selling stock?

Recorded transactions: 7 open-market purchases ($42K) and 0 open-market sales () across all tracked filings.

Where can I see all of SKIBSTED RUSSELL's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

SKIBSTED RUSSELL — SEC Form 4 Insider Trading Activity